MacroGenics Provides Update on Corporate Progress and 2020 Financial Results

NEXT STORY
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
PREV STORY
Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case

author_avatar
NASDAQ Market News

Global Neuromodulation Market to Reach US$8.9 Billion by the Year 2027

author_avatar
NASDAQ Market News

NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis

author_avatar
NASDAQ Market News